XML 54 R41.htm IDEA: XBRL DOCUMENT v3.8.0.1
Employee Benefit and Stock Compensation Plans Employee Benefit and Stock Compensation Plans (Tables)
12 Months Ended
Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Restricted Stock Activity
Information regarding nonvested shares of restricted stock awards outstanding for the years ended March 31 is as follows:
 
2017
 
2016
 
Shares
 
Weighted Average
Grant Price
 
Shares
 
Weighted Average
Grant Price
Outstanding, beginning of year
4,000

 
$
5.56

 

 
$

Granted

 

 
4,000

 
5.56

Vested
(800
)
 
5.56

 

 

Forfeited

 

 

 

Outstanding, end of year
3,200

 
$
5.56

 
4,000

 
$
5.56

Stock Options, Activity
Information regarding stock options as of and for the years ended March 31 is as follows:
 
2017
 
2016
 
Options
 
Weighted
Average
Exercise
Price
 
Options
 
Weighted
Average
Exercise
Price
Outstanding, beginning of year
5,924

 
$
81.65

 
3,029

 
$
246.18

Granted

 

 
4,000

 
5.56

Exercised

 

 

 

Expired/Forfeited
1,791

 
249.00

 
1,105

 
258.30

Outstanding, end of year
4,133

 
$
8.53

 
5,924

 
$
81.65

Exercisable, at year end
933

 
 
 
1,924

 
 


Shares Authorized under Stock Option Plans, by Exercise Price Range
Information regarding stock options as of March 31, 2017 is as follows :
 
 
 
Options Outstanding
 
Options Exercisable
Range of
Exercise Prices
 
Shares
 
Weighted
Average
Remaining
Life
 
Weighted
Average
Exercise
Price
 
Shares
 
Weighted
Average
Exercise
Price
$
5.00

$
5.99

 
4,000

 
8.23
 
$
5.56

 
800

 
$
5.56

90.00

$
104.85

 
133

 
3.36
 
97.50

 
133

 
97.50

 Total
 
 
4,133

 
 
 
 
 
933

 
 
Stock Options, Valuation Assumptions
The fair value of the option grants was estimated on the date of the grant using the Black-Scholes option pricing model applying the following weighted average assumptions for the years ended March 31:
 
2017
 
2016
Risk-free interest rate
N/A
 
1.78%
Volatility
N/A
 
10.00%
Annual dividends
N/A
 
—%
Expected life of option grants
N/A
 
9.24